Back to search
FDAFDA · Food and drugs·Recall number D-1377-2020

Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.

Published July 15, 2020 · Recall initiated: June 23, 2020

Summary

FDA records drug Class III recall D-1377-2020, published July 15, 2020 and initiated June 23, 2020. Recalling firm: VistaPharm, Inc.; Status: Terminated; Reported quantity: 380,700 cups; Lot: Lot #: a) 619800, Exp. 12/31/2020; 626200, Exp. 01/31/2021; b) 619800X,Exp. 12/31/2020; 626200X, Exp. 01/31/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
VistaPharm, Inc.
Distributor
United States including Puerto Rico
Lot
Lot #: a) 619800, Exp. 12/31/2020; 626200, Exp. 01/31/2021; b) 619800X,Exp. 12/31/2020; 626200X, Exp. 01/31/2021.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99. recalled?

Yes. FDA published recall D-1377-2020 on July 15, 2020. Reported hazard: Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

What should I do if I have this product?

Voluntary: Firm initiated · Letter